Sommaire

• Editorial

  • ·A Turning Point in Alzheimer’s Research: Harmonized Research Strategies and Novel Investments in Public Health Infrastructure Are Reenergizing the Field, and Rekindling Hope for Those Affected by Alzheimer’s and Related Dementias

    Page :214-216

    M.C. Carrillo, Heather M. Snyder, R. Conant, S. Worley, R. Egge

    Plan Plan
  • ·Can Digital Technology Advance the Development of Treatments for Alzheimer’s Disease?

    Page :217-220

    Marie Mc Carthy, P. Schueler

    Résumé Résumé Plan Plan  

• Commentary

  • ·Is a Large-Scale Screening for Alzheimer’s Disease Possible? Yes, in a Few Years

    Page :221-222

    F. Ribaldi, Daniele Altomare, G.B. Frisoni

    

• Brief Reports

  • ·The 2018 Revised FDA Guidance for Early Alzheimer’s Disease: Establishing the Meaningfulness of Treatment Effects

    Page :223-227

    Chris J. Edgar, G. Vradenburg, J. Hassenstab

    Résumé Résumé Plan Plan  
  • ·Randomized, Placebo Controlled Trial of NPT088, A Phage-Derived, Amyloid-Targeted Treatment for Alzheimer’s Disease

    Page :228-231

    D. Michelson, M. Grundman, K. Magnuson, Richard Fisher, J.M. Levenson, P. Aisen, K. Marek, M. Gray, F. Hefti

    Résumé Résumé Plan Plan  
  • ·Alzheimer’s Disease Composite Score: a Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer’s Disease

    Page :232-236

    Suzanne B. Hendrix, H. Soininen, A.M.J. van Hees, N. Ellison, P.J. Visser, A. Solomon, A. Attali, K. Blennow, M. Kivipelto, T. Hartmann

    Résumé Résumé Plan Plan  
  • ·Comparing the Standard and Electronic Versions of the Alzheimer’s Disease Assessment Scale — Cognitive Subscale: A Validation Study

    Page :237-241

    Todd M. Solomon, J.M. Barbone, H.T. Feaster, D.S. Miller, G.B. deBros, C.A. Murphy, D. Michalczuk

    Résumé Résumé Plan Plan  

• Short Communication

  • ·Neuropsychological, Psychiatric, and Functional Correlates of Clinical Trial Enrollment

    Page :242-247

    Dustin B. Hammers, N.L. Foster, J.M. Hoffman, T.H. Greene, K. Duff

    Résumé Résumé Plan Plan  

• Original Research

  • ·Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer’s Disease using Cerebrospinal Fluid Biomarkers in the AIBL Study

    Page :248-255

    Samantha C. Burnham, P.M. Coloma, Q.-X. Li, S. Collins, G. Savage, S. Laws, J. Doecke, P. Maruff, R.N. Martins, D. Ames, C.C. Rowe, C.L. Masters, V.L. Villemagne

    Résumé Résumé Plan Plan   
  • ·Prospective Evaluation of Cognitive Health and Related Factors in Elderly at Risk for Developing Alzheimer’s Dementia: A Longitudinal Cohort Study

    Page :256-266

    C. Udeh-Momoh, G. Price, M.T. Ropacki, N. Ketter, T. Andrews, H.M. Arrighi, H.R. Brashear, C. Robb, D.T. Bassil, M. Cohn, L.K. Curry, B. Su, D. Perera, P. Giannakopoulou, J. Car, H.A. Ward, R. Perneczky, Gerald Novak, L. Middleton

    Résumé Résumé Plan Plan  
  • ·Mediterranean-Dash Intervention for Neurodegenerative Delay (MIND) Diet Slows Cognitive Decline After Stroke

    Page :267-273

    Laurel Cherian, Y. Wang, K. Fakuda, S. Leurgans, N. Aggarwal, M. Morris

    Résumé Résumé Plan Plan  
  • ·Financial Management Skills in Aging, MCI and Dementia: Cross Sectional Relationship to 18F-Florbetapir PET Cortical β-amyloid Deposition

    Page :274-282

    Sierra Tolbert, Y. Liu, C. Hellegers, J.R. Petrella, M.W. Weiner, T.Z. Wong, P. Murali Doraiswamy, ADNI Study Group

    Résumé Résumé Plan Plan